Abstract
Traditional pharmaceutics and therapies do not allow early and reliable diagnosis of malignant tumors and do not guarantee that a therapy optimal for each specific patient is prescribed. Traditional anticancer drugs and therapies fail to ensure full recovery of patients at late oncogenesis stages. Therefore, search for new anticancer drugs and development of their application strategies is in progress. Among recent findings we could mention magnetically controlled therapeutic and diagnostic nanopreparations (MNPs), techniques for tumor visualization and contrast agents for tumor diagnosis, as well as techniques for drug delivery to damaged cells and therapy [1–10].
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
